SIRISREETREERUX, S.; BUNNAG, P. Aspirin for the primary prevention of cardiovascular disease in type 2 diabetes. The Journal of Chulabhorn Royal Academy, Bangkok, Thailand, v. 2, n. 4, p. 54–62, 2020. Disponível em: https://he02.tci-thaijo.org/index.php/jcra/article/view/243011. Acesso em: 18 may. 2024.